Nutrien Ltd. (NTR)
NYSE: NTR · Real-Time Price · USD
68.55
-1.10 (-1.58%)
At close: May 29, 2026, 4:00 PM EDT
68.73
+0.18 (0.27%)
After-hours: May 29, 2026, 7:52 PM EDT
Nutrien Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,914 | 2,297 | 700 | 1,699 | 10,431 | 4,018 |
Depreciation & Amortization | 2,862 | 2,369 | 2,339 | 2,874 | 2,730 | 2,466 |
Stock-Based Compensation | 299.95 | 163 | 37 | -18.55 | 85.49 | 250.26 |
Other Adjustments | 10.48 | 14 | 588 | 1,312 | -1,057 | 171.89 |
Change in Receivables | -1,610 | -128 | -224 | 1,165 | -1,247 | -2,109 |
Changes in Inventories | - | - | - | - | - | -1,844 |
Changes in Accounts Payable | -40.94 | -98 | -323 | -2,316 | 1,273 | 2,141 |
Changes in Other Operating Activities | 390.96 | -610 | 418 | 1,998 | -1,210 | -182 |
Operating Cash Flow | 4,821 | 4,007 | 3,535 | 6,712 | 11,005 | 4,912 |
Operating Cash Flow Growth | 54.10% | 13.35% | -47.34% | -39.01% | 124.06% | 16.11% |
Capital Expenditures | -2,310 | -2,005 | -2,154 | -3,445 | -3,358 | -2,381 |
Purchases of Investments | -124.82 | -94 | -112 | -41.07 | - | - |
Proceeds from Sale of Investments | 688.54 | 838 | 138 | - | - | - |
Payments for Business Acquisitions | -81.51 | -23 | -21 | -202.72 | -552.28 | -111.23 |
Other Investing Activities | -157.04 | -88 | 16 | -230.55 | -25.78 | 208.55 |
Investing Cash Flow | -1,985 | -1,372 | -2,133 | -3,919 | -3,937 | -2,284 |
Long-Term Debt Issued | - | 998 | 1,022 | 1,987 | 1,418 | 108.7 |
Long-Term Debt Repaid | -1,775 | -1,508 | -1,061 | -1,355 | -1,224 | -3,200 |
Net Long-Term Debt Issued (Repaid) | -1,775 | -510 | -39 | 632.02 | 194.04 | -3,092 |
Issuance of Common Stock | 106.94 | 38 | 18 | 43.72 | 227.97 | 252.78 |
Repurchase of Common Stock | -645.24 | -551 | -184 | -1,387 | -6,133 | -1,308 |
Net Common Stock Issued (Repurchased) | -538.3 | -513 | -166 | -1,344 | -5,905 | -1,055 |
Common Dividends Paid | -1,257 | -1,061 | -1,060 | -1,367 | -1,399 | -1,321 |
Other Financing Activities | 804.12 | -733 | -188 | -651.9 | 690.69 | 1,672 |
Financing Cash Flow | -2,766 | -2,817 | -1,453 | -2,731 | -6,420 | -3,796 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 36.96 | 30 | -37 | -9.27 | -103.13 | -39.18 |
Net Cash Flow | 107.16 | -152 | -88 | 53 | 545.49 | -1,207 |
Free Cash Flow | 2,511 | 2,002 | 1,381 | 3,267 | 7,646 | 2,530 |
Free Cash Flow Growth | 25.44% | 44.97% | -57.73% | -57.27% | 202.19% | 12.05% |
FCF Margin | 7.40% | 7.45% | 5.32% | 8.49% | 14.87% | 7.22% |
Free Cash Flow Per Share | 5.18 | 4.11 | 2.79 | 6.57 | 14.16 | 4.43 |
Levered Free Cash Flow | 2,005 | 1,413 | 915 | 1,410 | 10,022 | 1,093 |
Unlevered Free Cash Flow | 4,212 | 2,251 | 1,645 | 1,579 | 10,438 | 4,809 |